- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Tenesmus.
Displaying page 1 of 1.
EudraCT Number: 2006-003340-33 | Sponsor Protocol Number: Antrorect01-06 | Start Date*: 2006-12-21 | |||||||||||
Sponsor Name:BRACCO | |||||||||||||
Full Title: Preliminary evaluation of efficacy and tolerability of the association mesalazine 1g nifedipine 10mg in the treatment of tenesmus in patients suffering of distal ulcerative cholitis. Open study, ... | |||||||||||||
Medical condition: Tenesmus in patients with distal ulcerative cholitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004526-24 | Sponsor Protocol Number: Panbio/CR/0042006/CT | Start Date*: 2008-09-23 | |||||||||||
Sponsor Name:Panacea Biotec Ltd | |||||||||||||
Full Title: A double-blind, randomized, placebo-controlled, multicentre study to assess the efficacy and safety of Euphorbia Prostrata Dry Extract Tablets in patients of 1° and 2° internal haemorrhoids | |||||||||||||
Medical condition: Male and female subjects, at least 18 years of age with a diagnosis of internal haemorrhoids (1° and 2°) confirmed by protoscopic examination and suffering form an uncomplicated and untreated acute... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003792-19 | Sponsor Protocol Number: FOS-PROST-001 | Start Date*: 2021-03-04 |
Sponsor Name:Hospital Universitari Mutua Terrassa | ||
Full Title: Fosfomycin as an oral alternative treatment for acute bacterial prostatitis due to multi-drug resistant Escherichia coli. Pilot study | ||
Medical condition: Acute bacterial prostatitis due to multi-drug resistant Escherichia coli | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004676-22 | Sponsor Protocol Number: M16-066 | Start Date*: 2019-01-14 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) SK (Trial now transitioned) AT (Trial now transitioned) ES (Ongoing) SE (Trial now transitioned) NL (Trial now transitioned) DK (Completed) GR (Trial now transitioned) PL (Trial now transitioned) DE (Trial now transitioned) LT (Trial now transitioned) PT (Trial now transitioned) GB (GB - no longer in EU/EEA) LV (Trial now transitioned) SI (Trial now transitioned) BG (Trial now transitioned) HR (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004677-40 | Sponsor Protocol Number: M16-067 | Start Date*: 2018-11-29 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SK (Completed) AT (Completed) SE (Completed) ES (Ongoing) NL (Completed) PT (Completed) GR (Completed) DK (Completed) LT (Completed) PL (Completed) DE (Completed) GB (GB - no longer in EU/EEA) LV (Completed) SI (Completed) BG (Completed) HR (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003169-19 | Sponsor Protocol Number: CYC-201 | Start Date*: 2009-11-09 | |||||||||||
Sponsor Name:Sigmoid Pharma Ltd | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapusle Formulation of Ciclosporin (CyCol™) in the Treatment of Ulcerative Colitis | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
